A liver-infiltrating CD4+ Tfh1 cell response predicts HCV control, hepatitis, and seroconversion during acute infection

Journal:

Journal of Clinical Investigation

Published:

2025-09-16

DOI:

10.1172/jci178089

Affiliations:

6

Authors:

11

Go to article

Institutions	Authors	Share
OSU Department of Pediatrics (Nationwide Children's Hospital), United States of America (USA)	7.000000	0.64
Texas Biomedical Research Institute (Texas Biomed), United States of America (USA)	1.000000	0.09
Hospital of the University of Montreal (CHUM), Canada	1.000000	0.09
Woodruff Health Sciences Center (WHSC), Emory University, United States of America (USA)	1.000000	0.09
The Ohio State University (OSU), United States of America (USA)	1.000000	0.09

Interested in Immunology?